Biofilms Treatment Market to Grow at a CAGR of 7.5% to reach US$ 2,825.80 Mn Million from 2019 to 2027

Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Debridement Equipment, Gauzes and Dressings, Grafts and Matrices, and Other Products), Wound Type (Traumatic and Surgical Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Other Wounds), and End User (Hospitals, Home Care Settings, and Other End Users)

  • Report Code : TIPRE00015873
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 200
Buy Now

The biofilms treatment market was valued at US$ 1,590.31 million in 2019 and is projected to reach US$ 2,825.80 million by 2027; it is expected to grow at a CAGR of 7.5% during 2020–2027.

Biofilms are composed of mixed strains of fungi, bacteria, yeasts, algae, and other microbes. A biofilm develops on the wound surface when certain types of bacteria or fungi adhere to the wound surface and form a matrix over it. Viscous and shiny substances with unpleasant smell are secreted. The rising diabetes cases, increasing incidence of skin injuries due to burns and ulcers wounds, and growing number of surgical procedures across the world fuel the biofilms treatment market growth. Moreover, the rising number of innovations in wound care products is expected to drive market growth during the forecast period. However, the high cost associated with wound care management hinders the growth of the biofilms treatment market.

Lucrative Regions for Biofilms Treatment Market

Lucrative Regions for Biofilms Treatment Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Increasing Incidence of Wounds and Ulcers

Rising risks associated with diabetes such as diabetic foot ulcers and pressure sores accelerate demand for advanced bioactive wound care management products. In addition, the prevalence of noncommunicable diseases is increasing due to factors such as antimicrobial resistance, unhealthy lifestyles, alcohol consumption, and smoking. As per the International Diabetes Federation, in 2019, ~463 million adults were affected by diabetes, and the number of adult patients suffering from diabetes is expected to reach 700 million by 2045. As per the International Diabetes Federation, diabetes patients are 15–40 times more likely to require lower-leg amputation. Approximately 85% of amputations are carried out due to the development of a neuropathic foot ulcer.

Product-Based Insights

Based on product, the biofilms treatment market is segmented into debridement equipment, gauzes and dressings, grafts and matrices, and other products. The gauzes and dressings segment held the largest share of the market in 2019. The same segment is anticipated to register the highest CAGR in the market during the forecast period. Many companies are developing advanced dressings to prevent biofilms. For instance, ConvaTec Inc. has developed Hydrofiber Technology, where the soft absorbent dressing material forms a gel when it comes in contact with wound fluid. The technology reduces the dead space where bacteria can grow, and it also provides rapid and sustained antimicrobial activity.

Gauzes are available in woven and nonwoven forms, which have high absorbency and can be applied on both infected and noninfected wounds.

Global Biofilms Treatment Market, by Product – 2019 and 2027

Global Biofilms Treatment Market, by Product – 2019 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Wound Type-Based Insights

Based on wound type, the biofilms treatment market is segmented into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other wounds. The traumatic and surgical wounds segment held the largest share of the market in 2019. The same segment is anticipated to register the highest CAGR in the market during the forecast period. The most common traumatic wounds are open fractures, avulsions, and penetrating wounds. According to data published by Centers of Disease Control and Prevention (CDC) in 2019, ~800,000 patients get hospitalized in the US for hip injuries each year. Furthermore, ~300,000 adult patients get hospitalized due to hip fractures. As per the HCUP Statistical Brief, ~22 million visits—of the total annual visits—were reported in the emergency department for the treatments of trauma and accident injury in the US. The growing number of road accidents and sports injuries favors the market growth for traumatic and surgical wounds segment.

End User-Based Insights

Based on end user, the biofilms treatment market is segmented into hospitals, home care settings, and other end users. The hospitals segment held the largest share of the market in 2019. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period. The growth of the market for this segment is attributed to the increasing incidence of burn injuries across the world, especially in low-income countries. Hospitals are the primary healthcare centers approached by a patient seeking first aid and treatment for injuries. In general, patients prefer to visit clinics and hospitals than other healthcare centers. These centers offer various services and good quality treatment, with quick availability of the required equipment. Moreover, the fees for the treatments are reimbursed.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Biofilms Treatment Market: Strategic Insights

biofilms-treatment-market
Market Size Value inUS$ 1,590.31 Million in 2019
Market Size Value byUS$ 2,825.80 Million by 2027
Growth rateCAGR of 7.5% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Various companies operating in the biofilms treatment market perform strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain the brand name, and meet the growing demand from end users.

Biofilms Treatment Market – by Product

  • Gauzes and Dressings
  • Debridement Equipment
  • Grafts and Matrices
  • Other Product

Biofilms Treatment Market – by Wound Type

  • Traumatic and Surgical Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Other Wounds

Biofilms Treatment Market – by End User

  • Hospitals
  • Home Care Settings
  • Other End Users

Biofilms Treatment Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific(APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America (SAM)

    • Brazil
    • Argentina
    • Rest of SAM

Company Profiles

  • Smith & Nephew plc
  • MiMedx Group Inc.
  • ConvaTec Group plc
  • Coloplast A/S 
  • Mölnlycke Healthcare AB
  • Organogenesis Holdings Inc.
  • Integra LifeSciences Holdings Corporation
  • B. Braun Melsungen AG 
  • PAUL HARTMANN AG
  • Medline Industries Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product , Wound Type , and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is biofilms treatment?

Biofilms are composed of mixed strains of fungi, bacteria, yeasts, algae, and other microbes. A biofilm develops on the wound surface when certain types of bacteria or fungi adhere to the wound surface and form a matrix over it. Viscous and shiny substances with unpleasant smell are secreted. The rise in several diabetes cases, as well as skin injuries due to burns, is expected to fuel the growth of the biofilms treatment market during the estimated period.

What are the driving factors for the biofilms treatment market across the globe?

The rising diabetes cases, increasing incidence of skin injuries due to burns and ulcers wounds, and growing number of surgical procedures across the world fuel the biofilms treatment market growth. Moreover, the rising number of innovations in wound care products is expected to drive market growth during the forecast period.

What are the factors that are hampering the biofilms treatment market?

The cost of the treatment varies as per the healthcare setting. For instance, the cost of treatment is higher in a hospital than in an outpatient setting. Additionally, the type of dressing or therapy will also have an impact on cost-effectiveness. The high cost associated with wound care management is hampering market growth.

The List of Companies - Biofilms Treatment Market

  1. Smith & Nephew plc
  2. MiMedx Group Inc.
  3. ConvaTec Group plc
  4. Coloplast A/S  
  5. Mölnlycke Healthcare AB
  6. Organogenesis Holdings Inc.
  7. Integra LifeSciences Holdings Corporation
  8. B. Braun Melsungen AG  
  9. PAUL HARTMANN AG
  10. Medline Industries Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biofilms Treatment Market